GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, has announced the closing of an oversubscribed US$100 million Series E equity financing. The financing was led by new investor Viking Global Investors, with participation from key existing investors, including MVM Partners, Gilde Healthcare, Evidity Health Capital, Medtech Venture Partners, and FemHealth Ventures.
Latham & Watkins LLP advised GT Medical Technologies in the transaction with an Emerging Companies & Growth team led by Bay Area partner Luke Bergstrom, with associates Omar Ammash, Erica Kucharski, and Farah Arif.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.